Galmed Pharma (GLMD) Reports Q1 Loss of $0.62

May 22, 2025 4:42 PM

Galmed Pharma (NASDAQ: GLMD) reported Q1 EPS of ($0.62).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.